According to Titan Pharmaceuticals
's latest financial reports the company has $6.64 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $1.36 M | -73.47% |
2021-12-31 | $5.13 M | 45.47% |
2020-12-31 | $3.53 M | 146.48% |
2019-12-31 | $1.43 M | -79.02% |
2018-12-31 | $6.83 M | 697.08% |
2017-12-31 | $0.85 M | -93.5% |
2016-12-31 | $13.19 M | 88.71% |
2015-12-31 | $6.99 M | -18.82% |
2014-12-31 | $8.61 M | 49.5% |
2013-12-31 | $5.76 M | -124.9% |
2012-12-31 | $-23.13 M | 15.19% |
2011-12-31 | $-20.08 M | 231.72% |
2010-12-31 | $-6.06 M | 2824.15% |
2009-12-31 | $-0.21 M | |
2007-12-31 | $26.58 M | 128.3% |
2006-12-31 | $11.64 M | -29.85% |
2005-12-31 | $16.6 M | -52.51% |
2004-12-31 | $34.95 M | -23.46% |
2003-12-31 | $45.66 M | -36.56% |
2002-12-31 | $71.98 M | -28.99% |
2001-12-31 | $0.10 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 1,035,341.13% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 598,454.65% | ๐จ๐ญ Switzerland |
Vanda Pharmaceuticals VNDA | $0.54 B | 8,104.00% | ๐บ๐ธ USA |
Repligen
RGEN | $1.97 B | 29,577.81% | ๐บ๐ธ USA |
MediciNova MNOV | $62.37 M | 839.15% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.42 B | 6,361.47% | ๐บ๐ธ USA |